Terms: = Uterine cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Treatment
33 results:
1. Effect of 3D laparoscopy versus traditional laparotomy on serum tumor markers and coagulation function in patients with early-stage endometrial cancer.
Chen H; Xu D; Yu Y; Huang J; Zhou Q; Wang Q
Clinics (Sao Paulo); 2024; 79():100337. PubMed ID: 38368841
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
3. Serum he4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study.
Barr CE; Sergeant JC; Agnew HJ; Bolton J; McVey RJ; Crosbie EJ
BJOG; 2023 Jul; 130(8):941-948. PubMed ID: 36715558
[TBL] [Abstract] [Full Text] [Related]
4. A Rehabilitation Model Conducive to Postoperative Recovery of Endometrial cancer Patients after Laparoscopy.
Yang L; Han F
Biomed Res Int; 2022; 2022():9910841. PubMed ID: 36093393
[TBL] [Abstract] [Full Text] [Related]
5. Comparison between Pelvic IMRT and 3D-CRT in Combination with Chemotherapy via Nrf2 Expression on the High-Risk Endometrial cancer.
Wang N; Zhang X; Xu S; Li X; Meng Y; Dou Z
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):267-273. PubMed ID: 35818187
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of early recurrencies of uterine body cancer based on monitoring of serum biological markers.
Kovalenko NV; Verenikina EV; Maksimov AY; Gladkikh ON; Demidova AA; Domashenko EV
Klin Lab Diagn; 2022 Apr; 67(4):197-203. PubMed ID: 35575391
[TBL] [Abstract] [Full Text] [Related]
7. Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical cancer.
Hwang WY; Suh DH; Kim K; Kim YB; No JH
Cancer Control; 2022; 29():10732748221097778. PubMed ID: 35506739
[TBL] [Abstract] [Full Text] [Related]
8. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer.
Ma X; Ren X; Ma F; Cai S; Ning C; Liu J; Chen X; Zhang G; Qiang J
Gynecol Oncol; 2022 Jun; 165(3):594-602. PubMed ID: 35469683
[TBL] [Abstract] [Full Text] [Related]
9. Endometriosis in para-aortic lymph node resembling a malignancy: a case report and literature review.
Li J; Liu Y; Du K; Xiao L; He X; Dai F; Tang J
BMC Womens Health; 2022 Apr; 22(1):101. PubMed ID: 35379213
[TBL] [Abstract] [Full Text] [Related]
10. The Efficacy of Psychological Care and Chinese Herbal Decoction in Postoperative Chemotherapy Patients with Endometrial cancer.
Liu J; Wang J; Guo Y; Zhang H
J Healthc Eng; 2022; 2022():5700637. PubMed ID: 35222888
[TBL] [Abstract] [Full Text] [Related]
11. A prediction model based on clinical and histological features for predicting recurrence in patients with stage I-II endometrial cancer after surgical treatment.
Song W; Zhao Y
Ann Diagn Pathol; 2022 Feb; 56():151861. PubMed ID: 34953233
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer].
Chen J; Cao YJ; Zhu L; Zhang BL; Liu ZY; Hou HL; Chai YL; Wang P
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(8):597-601. PubMed ID: 33663192
[No Abstract] [Full Text] [Related]
13. Prognostic value of serum he4 level in the management of endometrial cancer: A pilot study.
Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
[TBL] [Abstract] [Full Text] [Related]
14. he4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
[TBL] [Abstract] [Full Text] [Related]
15. Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in cancer Cell Lines.
Kim KK; Singh RK; Khazan N; Kodza A; Singh NA; Jones A; Sivagnanalingam U; Towner M; Itamochi H; Turner R; Moore RG
Sci Rep; 2020 Feb; 10(1):3241. PubMed ID: 32094384
[TBL] [Abstract] [Full Text] [Related]
16. Role of serum he4 as a prognostic marker in carcinoma of the ovary.
Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
[TBL] [Abstract] [Full Text] [Related]
17. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Sep; 98(9):1086-1099. PubMed ID: 30793281
[TBL] [Abstract] [Full Text] [Related]
18. RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients.
Vezzoli M; Ravaggi A; Zanotti L; Miscioscia RA; Bignotti E; Ragnoli M; Gambino A; Ruggeri G; Calza S; Sartori E; Odicino F
Sci Rep; 2017 Sep; 7(1):10528. PubMed ID: 28874808
[TBL] [Abstract] [Full Text] [Related]
19. Novel algorithm including CA-125, he4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract] [Full Text] [Related]
20. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial cancer: A Prospective Study.
Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G
Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834
[TBL] [Abstract] [Full Text] [Related]
[Next]
